Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Higher testosterone and testosterone/estradiol ratio in men are associated with better epigenetic estimators of mortality risk

medRxiv(2023)10.1101/2023.02.16.23285997Source: DataRank Database

Higher testosterone and testosterone/estradiol ratio in men are associated with better epigenetic estimators of mortality risk is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.208. It has been cited 3 times.

N/A

0.208DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (16)IDs (PubMed, OpenAlex)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.208

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Kimberly C. Paul ORCID,Ake T Lu,Luigi Ferrucci ORCID,Beate Ritz ORCID,Alexandra M. Binder ORCID

Live enrichment

PubMed:36865294 OpenAlex:https://openalex.org/W4321606069

National Institutes of Health

Grant: N01AA000002-017

SAMPLE SURVEYS OF NATL DRUG &ALC TRTMT UNITS CLIENTS

National Institutes of Health

Grant: 7K07CA225856-03

Epigenetic Age as a Marker of Reproductive Age and Modifier of Invasive Breast Cancer Risk Among Postmenopausal Women

National Institutes of Health

Grant: 5U01AG060908-05

Validation and optimization of epigenetic clocks

National Institutes of Health

Grant: 5F32AG063442-02

Sex Hormones, Aging, Alzheimer's Disease and Other Neurodegenerative Diseases in Women

National Institutes of Health

Grant: 5K01AG072044-02

Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study

National Institutes of Health

Grant: 5R01AG027012-03

Oxidative stress and the pathogenesis of sarcopenia and*

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/07/30/2023.02.16.23285997.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.02.16.23285997

repositoryhttps://doi.org/10.1101/2023.02.16.23285997

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36865294

Fields of Study

Epigenetics and DNA MethylationSex and Gender in HealthcareHormonal and reproductive studies0301 basic medicine03 medical and health sciences

Keywords

Testosterone (patch)EpigeneticsInternal medicineEndocrinologyMedicineDemographyBiologySociologyGeneticsGeneArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 0: Good health and well-being